Inactief instrument

Andere talen Caribbean International Holdings Inc Other OTC

Aandelen

US1418201000

slotkoers Other OTC Andere beurzen
- ^USD	-

2023

NovaBay gaat het amnionweefsel allograft van BioStem commercialiseren

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments	14:15
BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM)	14:02
BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM)	10:34
BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers	10/07
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study	26/06
UPDATE -- PRISM MarketView Showcases BioStem Technologies: Impressive Revenue Growth and Strategic Expansion	17/06
BioStem Technologies to Sponsor MRO Better Half Dash	29/05
4 Stocks to Watch in the Booming Regenerative Medicine Market	20/05
Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M	14/05
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million	14/05
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024	07/05
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent	06/05
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts	30/04
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase	25/04
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange	24/04
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference	02/04
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase	01/04
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024	21/03
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market	26/02
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies	30/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Caribbean International Holdings Inc Other OTC

Aandelen

US1418201000

Andere talen

Filters